JOINT FILING AGREEMENT
Exhibit 99.1
The undersigned agree that the attached Schedule 13G dated July 24, 2020 relating to the ordinary shares, nominal value £0.05 per share, of Verona Pharma Plc shall be filed on behalf of the undersigned.
Dated: July 24, 2020
AI BIOTECHNOLOGY LLC | ||||
By: Access Industries Management, LLC, Its Manager | ||||
/s/ Xxxxxxxxx Xxxxxx | ||||
Signature | ||||
Xxxxxxxxx Xxxxxx / Executive Vice President | ||||
Name/Title | ||||
ACCESS INDUSTRIES HOLDINGS LLC | ||||
By: Access Industries Management, LLC, Its Manager | ||||
/s/ Xxxxxxxxx Xxxxxx | ||||
Signature | ||||
Xxxxxxxxx Xxxxxx / Executive Vice President | ||||
Name/Title | ||||
ACCESS INDUSTRIES MANAGEMENT, LLC | ||||
By: | ||||
/s/ Xxxxxxxxx Xxxxxx | ||||
Signature | ||||
Xxxxxxxxx Xxxxxx / Executive Vice President | ||||
Name/Title | ||||
* | ||||
Signature | ||||
Xxx Xxxxxxxxx | ||||
Name |
* | The undersigned, by signing his name hereto, executes this Joint Filing Agreement pursuant to the Power of Attorney executed on behalf of Xx. Xxxxxxxxx (filed as Exhibit 99.2 to his Schedule 13G related to the common stock of Pandion Therapeutics, Inc. filed on July 24, 2020). |
By: | /s/ Xxxxxxxxx Xxxxxx | |
Name: | Xxxxxxxxx Xxxxxx | |
Attorney-in-Fact |